InvestSMART

PainChek Ltd (ASX: PCK) - Announcements

Current share price for PCK : $0.073 0.005 (6.41%)+

ASX company news and announcements for PainChek Ltd (PCK) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All PainChek Ltd (PCK) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than PainChek Ltd (PCK), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for PainChek Ltd (PCK)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$15 John Murray retires as PainChek non-executive director 26 Oct 2026 9:05AM $0.078 $0.073 fallen by 6.41%
$15 Notification regarding unquoted securities - PCK 13 Oct 2026 12:50PM $0.105 $0.073 fallen by 30.48%
$15 PainChek expands Sabra contracts to 23 US communities 13 Oct 2026 9:09AM $0.099 $0.073 fallen by 26.26%
$15 Change of Director's Interest Notice x3 30 Sep 2026 3:41PM $0.096 $0.073 fallen by 23.96%
$15 Application for quotation of securities - PCK 30 Sep 2026 3:36PM $0.096 $0.073 fallen by 23.96%
$15 Notice of Annual General Meeting/Proxy Form 30 Sep 2026 12:25PM $0.096 $0.073 fallen by 23.96%
$15 Corporate Governance Statement and Appendix 4G 2026 23 Sep 2026 10:46AM $0.110 $0.073 fallen by 33.64%
$15 Annual Report to shareholders 23 Sep 2026 9:46AM $0.110 $0.073 fallen by 33.64%
$15 Final Director's Interest Notice 8 Sep 2026 1:05PM $0.115 $0.073 fallen by 36.52%
$15 Investor Webinar Invite 3 Sep 2026 10:08AM $0.100 $0.073 fallen by 27%
$15 Resignation of Non-Executive Director 2 Sep 2026 3:59PM $0.098 $0.073 fallen by 25.51%
$15 Appendix 4E and Financial Report 28 Aug 2026 5:53PM $0.094 $0.073 fallen by 22.34%
$15 PainChek Investor Webinar 7 Aug 2026 1:44PM $0.100 $0.073 fallen by 27%
$15 Update - Notification regarding unquoted securities - PCK 5 Aug 2026 5:12PM $0.100 $0.073 fallen by 27%
$15 Change of Director's Interest Notice x 4 5 Aug 2026 5:10PM $0.100 $0.073 fallen by 27%
$15 Quarterly Activities/Appendix 4C Cash Flow Report 29 Jul 2026 9:58AM $0.105 $0.073 fallen by 30.48%
$15 PainChek receives $1.123 million R&D tax incentive refund 22 Jul 2026 8:29AM $0.100 $0.073 fallen by 27%
$15 US MedTech leader Karen Holzberger appointed CEO 20 Jul 2026 8:58AM $0.105 $0.073 fallen by 30.48%
$15 Final Director's Interest Notice 8 Jul 2026 1:44PM $0.115 $0.073 fallen by 36.52%
$15 CEO Transition 6 Jul 2026 4:33PM $0.100 $0.073 fallen by 27%
$15 Notification of cessation of securities - PCK 3 Jul 2026 3:24PM $0.105 $0.073 fallen by 30.48%
$15 Change of Director's Interest Notice x5 26 Jun 2026 5:12PM $0.100 $0.073 fallen by 27%
$15 Notification regarding unquoted securities - PCK 26 Jun 2026 4:19PM $0.100 $0.073 fallen by 27%
$15 PainChek secures initial Sabra US care facilities 4 Jun 2026 8:27AM $0.140 $0.073 fallen by 47.86%
$15 Notification regarding unquoted securities - PCK 28 May 2026 5:31PM $0.145 $0.073 fallen by 49.66%

1 - 25 of 482 results

Page 1 of 20

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.